Month: July 2025

Premier Anesthesia Partners with Salina Regional Health Center to Power Next Phase of Surgical Excellence

Collaboration to Optimize Anesthesia Services Through Tailored SolutionsALPHARETTA, Ga.--(BUSINESS WIRE)--Premier Anesthesia, a leading privately held single-specialty anesthesia practice management firm,...

Premier Anesthesia Partners with Salina Regional Health Center to Power Next Phase of Surgical Excellence

Collaboration to Optimize Anesthesia Services Through Tailored SolutionsALPHARETTA, Ga.--(BUSINESS WIRE)--Premier Anesthesia, a leading privately held single-specialty anesthesia practice management firm,...

Neural Advances Ethnobotanical Strategy Through Execution of SERFOR Research Agreement and CWE’s Exclusive German Distribution Agreement with Ritual Herbs

Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an...

Sharecare introduces Condition Masterclass to support patient education and health literacy for chronic disease management

Newest solution from Sharecare helps life sciences brands uniquely engage, educate, and activate patients, inspired by evidence-based Chronic Disease Self-Management...

Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq

SAN DIEGO, July 21, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a...

Kaida BioPharma Chairman and Founding Investor, Craig Pierson, to Present at Opal Group’s Family Office & Private Wealth Management Forum 2025

FORT LAUDERDALE, FL, July 21, 2025 (GLOBE NEWSWIRE) -- Kaida BioPharma (“Kaida” or the “Company”), an early-stage pharma company dedicated...

Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-approved Medical Maggot License for U.S. Market

SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“CUPR” or “the Company”), a biomedical and...

error: Content is protected !!